Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance
Wei Shu(Novartis (United States)), Weiwei Gao, Chao Wu, Xing-lu Yan, Xi-zhong Tian, Xuerui Huang, Qiping Ge(Capital Medical University), Furong Wang(Guangdong Medical College), Hong-zhe Cui, Youlun Li, Shengyu Chen, Senlin Chen(Central South University), Xiao-you Chen, Yuhui Chen(Nanjing Tech University), Yu-Jia Ning, Xiu-e Xi, Li Xie(Shanghai Jiao Tong University), Xue-yan Leng, Liu Qian-ying, Shi Lian(Beijing Tongren Hospital), Xiang Wu(East China Normal University), Hua Li(Jiading District Central Hospital), Lijie Zhang(Chinese Center For Disease Control and Prevention), Peng Zhang(Chinese Academy of Sciences), Ling Chen(Guangzhou Institutes of Biomedicine and Health), Fei Wang, Bo Li(Chongqing Normal University), Juan Li(Jiuquan Iron & Steel (China)), Liang Li(Zhejiang University), Yang ChengQing, Jian Du(Capital Medical University), Haiqing Zhang(Shandong University), Wenli Cao(Shenyang Pharmaceutical University), Liping Ma(Sichuan University), Junping Yan(Sun Yat-sen University), B. Ji, Guanglu Jiang, Yuxian Sun(Scripps Research Institute)
Cited by 0
Related Papers
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
|Cancer Discovery|2013|590
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|536